Recently-delayed approvals include a new drug designed to slow the effects of Lou Gehrig's disease, the french abortion pill RU-486, and new uses for thalidomide, which caused serious birth defects when first introduced in the 1950's.
CNN: FDA delays approval of new diet drug amid cancer concern